Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
根据最新的财务报表(Form-10K),Hinge Health Inc 的总资产为 $744,净损失为 $-424
HNGE 的关键财务比率是什么?
Hinge Health Inc 的流动比率是 2.03,净利 margin 为 -72.23,每股销售为 $10.75。
Hinge Health Inc 的收入按细分市场或地理位置如何划分?
Hinge Health Inc 最大收入来源是 Artificial Intelligence-Powered Motion Tracking Technology and Proprietary Electrical Nerve Stimulation Wearable Device,在最近的收益报告中收入为 390,404,000。就地区而言, United States 是 Hinge Health Inc 的主要市场,收入为 390,404,000。